×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
CRMD – cormedix inc. (US:AMEX)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
CRMD
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
4/15
09:27 am
crmd
CorMedix Outlines Post-Melinta Growth, Q2 REZZAYO Phase 3 Catalyst and DefenCath Reimbursement Shift [Yahoo! Finance]
Low
Report
CorMedix Outlines Post-Melinta Growth, Q2 REZZAYO Phase 3 Catalyst and DefenCath Reimbursement Shift [Yahoo! Finance]
4/8
03:05 am
crmd
CorMedix: A Shrinking Core And No Proven Second Engine [Seeking Alpha]
Low
Report
CorMedix: A Shrinking Core And No Proven Second Engine [Seeking Alpha]
4/7
08:30 am
crmd
CorMedix to Participate in Needham Virtual Healthcare Conference
Low
Report
CorMedix to Participate in Needham Virtual Healthcare Conference
4/2
12:05 pm
crmd
CorMedix: Waiting On Phase III ReSPECT For A Further Re-Rating (Upgrade) [Seeking Alpha]
Low
Report
CorMedix: Waiting On Phase III ReSPECT For A Further Re-Rating (Upgrade) [Seeking Alpha]
3/24
11:30 am
crmd
How The CorMedix (CRMD) Investment Story Is Shifting As Analyst Targets Reset [Yahoo! Finance]
Low
Report
How The CorMedix (CRMD) Investment Story Is Shifting As Analyst Targets Reset [Yahoo! Finance]
3/14
06:21 pm
crmd
CorMedix CEO touts Melinta pivot, DefenCath TDAPA transition and Q2 REZZAYO Phase 3 data at Leerink [Yahoo! Finance]
Low
Report
CorMedix CEO touts Melinta pivot, DefenCath TDAPA transition and Q2 REZZAYO Phase 3 data at Leerink [Yahoo! Finance]
3/14
05:36 pm
crmd
CorMedix Touts Q2 REZZAYO Data, Melinta Integration and DefenCath Reimbursement Shift at Conference [Yahoo! Finance]
Low
Report
CorMedix Touts Q2 REZZAYO Data, Melinta Integration and DefenCath Reimbursement Shift at Conference [Yahoo! Finance]
3/6
07:02 pm
crmd
CorMedix (CRMD) had its "outperform" rating reaffirmed by Leerink Partners.
Low
Report
CorMedix (CRMD) had its "outperform" rating reaffirmed by Leerink Partners.
Date
Time
Symbol
Headline
Impact
4/17
04:16 pm
crmd
Form PRE 14A CorMedix Inc. For: Apr 17
Low
Report
Form PRE 14A CorMedix Inc. For: Apr 17
3/26
05:49 pm
crmd
Form SCHEDULE 13G/A CorMedix Inc. Filed by: VANGUARD GROUP INC
Low
Report
Form SCHEDULE 13G/A CorMedix Inc. Filed by: VANGUARD GROUP INC
3/6
05:07 pm
crmd
Form 8-K CorMedix Inc. For: Mar 06
Low
Report
Form 8-K CorMedix Inc. For: Mar 06
3/5
08:32 am
crmd
Form 10-K CorMedix Inc. For: Dec 31
Medium
Report
Form 10-K CorMedix Inc. For: Dec 31
3/5
07:48 am
crmd
Form 8-K CorMedix Inc. For: Mar 05
High
Report
Form 8-K CorMedix Inc. For: Mar 05
2/6
09:30 pm
crmd
Form 4 CorMedix Inc. For: Feb 04 Filed by: Hurlburt Elizabeth
Low
Report
Form 4 CorMedix Inc. For: Feb 04 Filed by: Hurlburt Elizabeth
2/6
09:30 pm
crmd
Form 4 CorMedix Inc. For: Feb 04 Filed by: Zelnick Kaufman Beth
Low
Report
Form 4 CorMedix Inc. For: Feb 04 Filed by: Zelnick Kaufman Beth
2/6
09:30 pm
crmd
Form 4 CorMedix Inc. For: Feb 04 Filed by: Todisco Joseph
Low
Report
Form 4 CorMedix Inc. For: Feb 04 Filed by: Todisco Joseph
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
3/18
Form 4 CorMedix Inc. For: Mar 18 Filed by: Baluch Khoso
18.5%
6/10 CorMedix Inc. to Ring NYSE Closing Bell on Monday, June 10 17.1%
12/17 Form 4 CorMedix Inc. For: Dec 13 Filed by: Khan Mehmood 16.0%
3/19 Form 4 CorMedix Inc. For: Mar 18 Filed by: Mounts Phoebe 12.9%
7/16 Form 4 CorMedix Inc. For: Jul 12 Filed by: DUNTON ALAN W 8.7%
5/24 Form 3 CorMedix Inc. For: May 01 Filed by: Mounts Phoebe 6.5%
7/9 Form 8-K CorMedix Inc. For: Jul 09 6.3%
10/16 CorMedix Completes Successful CMC Interaction with the FDA 5.8%
5/17 Form 4 CorMedix Inc. For: May 15 Filed by: Dillione Janet 5.6%
11/14 CorMedix Inc. Reports Third Quarter 2019 Financial Results and Provides Business Update 5.5%
6/10 CorMedix Inc. to Ring NYSE Closing Bell on Monday, June 10 17.1%
12/17 Form 4 CorMedix Inc. For: Dec 13 Filed by: Khan Mehmood 16.0%
3/19 Form 4 CorMedix Inc. For: Mar 18 Filed by: Mounts Phoebe 12.9%
7/16 Form 4 CorMedix Inc. For: Jul 12 Filed by: DUNTON ALAN W 8.7%
5/24 Form 3 CorMedix Inc. For: May 01 Filed by: Mounts Phoebe 6.5%
7/9 Form 8-K CorMedix Inc. For: Jul 09 6.3%
10/16 CorMedix Completes Successful CMC Interaction with the FDA 5.8%
5/17 Form 4 CorMedix Inc. For: May 15 Filed by: Dillione Janet 5.6%
11/14 CorMedix Inc. Reports Third Quarter 2019 Financial Results and Provides Business Update 5.5%
TOP News Decliners
9/26
CorMedix Inc. Announces Exercises of Outstanding Warrants
-14.5%
5/13 Form 10-Q CorMedix Inc. For: Mar 31 -9.7%
8/1 CorMedix Inc. to Report Second Quarter 2019 Financial Results and Provide a Corporate Update on August 13 -5.9%
9/30 Form 4 CorMedix Inc. For: Sep 26 Filed by: Baluch Khoso -5.4%
9/20 Form 8-K CorMedix Inc. For: Sep 20 -4.5%
12/21 CorMedix Inc (NASDAQ: CRMD) had its "buy" rating re-affirmed by analysts at B. Riley. -4.5%
12/20 Trade Alert: The Independent Director Of CorMedix, Inc. (NYSEMKT:CRMD), Mehmood Khan, Has Just Spent US$112k Buying Shares [Yahoo! Finance News] -3.8%
2/6 Form 8-K CorMedix Inc. For: Jan 31 -3.6%
11/6 CorMedix Inc. Announces a Change to its Senior Leadership -3.5%
6/26 CorMedix Inc. Set to Join the Russell 2000® Index -3.5%
5/13 Form 10-Q CorMedix Inc. For: Mar 31 -9.7%
8/1 CorMedix Inc. to Report Second Quarter 2019 Financial Results and Provide a Corporate Update on August 13 -5.9%
9/30 Form 4 CorMedix Inc. For: Sep 26 Filed by: Baluch Khoso -5.4%
9/20 Form 8-K CorMedix Inc. For: Sep 20 -4.5%
12/21 CorMedix Inc (NASDAQ: CRMD) had its "buy" rating re-affirmed by analysts at B. Riley. -4.5%
12/20 Trade Alert: The Independent Director Of CorMedix, Inc. (NYSEMKT:CRMD), Mehmood Khan, Has Just Spent US$112k Buying Shares [Yahoo! Finance News] -3.8%
2/6 Form 8-K CorMedix Inc. For: Jan 31 -3.6%
11/6 CorMedix Inc. Announces a Change to its Senior Leadership -3.5%
6/26 CorMedix Inc. Set to Join the Russell 2000® Index -3.5%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: